Edwards Lifesciences Net Cash Flow from Financing Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 130.21  3.61  2.70%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow from Financing of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow or Change in Cash and Cash Equivalents representing the amount of cash inflow (outflow) from financing activities, from continuing and discontinued operations. Principal components of financing cash flow are: issuance (purchase) of equity shares, issuance (repayment) of debt securities, and payment of dividends & other cash distributions.
Net Cash Flow from Financing  10 Years Trend  
Decreasing
Slightly volatile
 Net Cash Flow from Financing 
      Timeline 

Edwards Lifesciences Net Cash Flow from Financing Over Time

2016-12-31 (268,500,000) 
2017-12-31 (268,500,000) 
2018-12-31 (224,789,474) 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean (141,983,806)
Geometric Mean  130,353,756
Coefficient Of Variation (57.50)
Mean Deviation  58,013,329
Median (135,200,000)
Standard Deviation  81,640,877
Range  303,400,000
R Value (0.61)
R Squared  0.38
Significance  0.02538
Slope (12,885,917)

Currently Trending

FB   
 NMS 
Purchased few shares of
a day ago ago
Traded for 179.96
CRM   
 NYQ 
Purchased over 20 shares of
a day ago ago
Traded for 113.12
MSFT   
 NMS 
Purchased over 30 shares of
a day ago ago
Traded for 92.66